France· FR:66287152
CHAMPIX 0,5 mg et 1 mg, comprimé pelliculé
A medicinal product containing tartrate de varénicline, registered in France by PFIZER EUROPE MA EEIG (BELGIQUE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TARTRATE DE VARÉNICLINE
- Manufacturer
- PFIZER EUROPE MA EEIG (BELGIQUE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400927332098plaquette(s) PVC aluminium de 11 comprimé(s) à 0, 5 mg - plaquette(s) PVC aluminium de 14 comprimé(s) à 1 mg dans un étui thermoscellé ( abrogée le 01/10/2024)EUR 24.74
- cip133400937718097plaquette(s) polychlortrifluoroéthylène PVC aluminium de 11 comprimé(s) - plaquette(s) polychlortrifluoroéthylène PVC aluminium de 14 comprimé(s) dans un étui thermoscelléEUR 19.81
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tartrate de varénicline in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCHANTIXPfizer Laboratories Div Pfizer Inc
- SpainBYTEQI 0,5 MG + 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGNeuraxpharm Spain S.L.
- SwedenCHAMPIX 0,5 mg + 1 mg Filmdragerad tablettPfizer Europe MA EEIG
- CzechiaCHAMPIXPfizer Europe MA EEIG, Bruxelles
- BelgiumChampix 0.5 mgPfizer Europe MA
- NetherlandsByteqi 0,5 mg filmomhulde tablettenneuraxpharm Arzneimittel GmbH
- FinlandChampixPfizer Europe MA EEIG
- NorwayChampixPfizer Europe MA EEIG (1)
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Civarenix, Civarenix Starterpackung
- Belgium · Varenicline Ab, Varenicline Eg
- Czechia · Civarenix, Varenicline Glenmark
- Germany · Vareniclin Ascend, Vareniclin Axunio
- Denmark · Civarenix, Vareniclin Axunio
- Spain · Byteqi, Cuitvar
- Finland · Varenicline Glenmark, Varenicline Orion
- United Kingdom (Northern Ireland) · Varenicline, Varenicline Accord
- Ireland · Varenicline Ascend, Varenicline Teva
- Iceland · Champix, Vareniclin Normon
- Italy · Civarenix, Vareniclina Aurobindo
- Liechtenstein · Champix
- Luxembourg · Vareniclin Ratiopharm, Vareniclin Starterpackung Ratiopharm
- Malta · Varenicline Glenmark
- Netherlands · Byteqi, Cuitvar
- Norway · Champix, Varenicline Bluefish
- Portugal · Cuitvar, Exchampra
- Sweden · Civarenix, Varenicline Bluefish
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/22537e96-fe44-4802-bc66-ac651998d9d7 GET /v1/drugs/22537e96-fe44-4802-bc66-ac651998d9d7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66287152",
"date_amm": "2006-09-26",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/06/360",
"substance": "TARTRATE DE VARÉNICLINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé et comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about tartrate de varénicline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.